Supplier
Geisinger Wyoming Valley Medical Center
Geisinger Wyoming Valley Medical Center was paid $2.52M by Medicaid between Jan 2019 and Dec 2024, across 112 billing codes. Its largest line is X0621, — 20% of everything it billed.
33Billing provider infoGEISINGER WYOMING VALLEY MEDICAL CENTER
WILKES BARRE, PA 18702
WILKES BARRE, PA 18702
33aNPI1437551868assigned 09/17/2014
33bProvider typeDurable Medical Equipment & Medical Supplies
28Total paid$2.52M
24GClaims85,854
24DCodes billed112
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers
Next to other Durable Medical Equipment & Medical Supplies providers in Pennsylvania
Rank by total paid#45 of 279
Median peer was paid$181K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MULL, CINDY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 444 | $292.04 | |
| 2020 | 7,906 | $160K | |
| 2021 | 30,313 | $867K | |
| 2022 | 16,282 | $576K | |
| 2023 | 15,338 | $468K | |
| 2024incomplete | 15,571 | $447K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| X0621 | 20% | 2,562 | 1,846 | $511K | |
| 87481 | 11% | 4,493 | 3,862 | $280K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 10% | 6,757 | 6,342 | $260K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 6.9% | 6,910 | 6,638 | $174K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 5.5% | 6,035 | 5,765 | $138K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 5.4% | 546 | 531 | $136K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 4.2% | 1,253 | 1,236 | $105K |
| 87150 | 3.6% | 2,250 | 2,210 | $91K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 3.1% | 2,650 | 2,590 | $78K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2.7% | 1,764 | 1,728 | $68K |
| 87631 | 2.0% | 377 | 357 | $51K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.7% | 5,436 | 5,280 | $44K |
100 more codes
| 87511 | 1.4% | 1,811 | $35K | |
| 17110 | 1.3% | 733 | $32K | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | 1.2% | 1,024 | $30K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.0% | 1,809 | $25K |
| 86803 | <1% | 1,164 | $22K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 643 | $18K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 232 | $18K |
| 81025 | <1% | 4,309 | $17K | |
| 11721 | <1% | 1,355 | $17K | |
| 76830 | Ultrasound, transvaginal | <1% | 290 | $17K |
| 96900 | <1% | 680 | $17K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,141 | $16K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 688 | $16K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,014 | $14K |
| 73630 | <1% | 995 | $13K | |
| 90715 | <1% | 1,510 | $12K | |
| 81513 | <1% | 205 | $12K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,258 | $12K |
| 11102 | <1% | 393 | $11K | |
| 80053 | Comprehensive metabolic panel | <1% | 866 | $10K |
| 82570 | <1% | 1,317 | $10K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 73 | $9K |
| 85027 | <1% | 1,123 | $8K | |
| 86762 | <1% | 388 | $8K | |
| Q3014 | Telehealth originating site facility fee | <1% | 554 | $8K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 15 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,251 | $7K |
| 87340 | <1% | 462 | $7K | |
| 86850 | <1% | 750 | $6K | |
| 11057 | <1% | 270 | $6K | |
| 88312 | <1% | 99 | $6K | |
| 80081 | <1% | 72 | $6K | |
| 77066 | Tomosynthesis, mammo | <1% | 66 | $5K |
| G0008 | Administration of influenza virus vaccine | <1% | 577 | $5K |
| 84156 | <1% | 1,267 | $5K | |
| 82728 | <1% | 435 | $5K | |
| 84702 | <1% | 303 | $5K | |
| 90686 | <1% | 428 | $5K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 232 | $5K |
| 86592 | <1% | 1,140 | $5K | |
| 87430 | <1% | 740 | $5K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 235 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,932 | $4K |
| 76642 | <1% | 109 | $4K | |
| 86901 | <1% | 843 | $4K | |
| 86900 | <1% | 842 | $4K | |
| 80061 | Lipid panel | <1% | 266 | $4K |
| 83540 | <1% | 433 | $4K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 47 | $3K |
| 11900 | <1% | 32 | $3K | |
| 11056 | <1% | 167 | $3K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 36 | $3K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 55 | $3K |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 65 | $3K |
| 77065 | Tomosynthesis, mammo | <1% | 44 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 63 | $3K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 963 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 251 | $2K |
| 83550 | <1% | 424 | $2K | |
| 88341 | <1% | 25 | $2K | |
| 76801 | <1% | 41 | $2K | |
| 86780 | <1% | 134 | $2K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 98 | $2K |
| 82950 | <1% | 293 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 290 | $2K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 99 | $2K |
| J2791 | Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu | <1% | 30 | $2K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 49 | $1K |
| 82607 | <1% | 109 | $1K | |
| 87186 | <1% | 150 | $1K | |
| 88342 | <1% | 28 | $1K | |
| 85046 | <1% | 176 | $1K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 15 | $973.70 |
| 73610 | <1% | 31 | $804.52 | |
| 81003 | <1% | 263 | $791.85 | |
| 17000 | <1% | 55 | $729.90 | |
| 84146 | <1% | 27 | $671.20 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 72 | $667.06 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 216 | $645.23 |
| 88304 | <1% | 63 | $594.56 | |
| 82746 | <1% | 46 | $543.36 | |
| 87101 | <1% | 54 | $521.44 | |
| 88142 | <1% | 29 | $452.64 | |
| 90656 | <1% | 175 | $423.48 | |
| 82565 | <1% | 62 | $375.78 | |
| 84439 | <1% | 45 | $374.16 | |
| 85610 | <1% | 75 | $239.12 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 276 | $226.20 |
| 58300 | <1% | 13 | $217.38 | |
| 87206 | <1% | 73 | $214.14 | |
| 86038 | <1% | 13 | $206.25 | |
| 51798 | <1% | 14 | $173.88 | |
| 85730 | <1% | 26 | $166.02 | |
| 82043 | <1% | 13 | $109.04 | |
| 85652 | <1% | 36 | $103.44 | |
| 87088 | <1% | 12 | $101.28 | |
| 87077 | <1% | 13 | $95.68 | |
| 84478 | <1% | 12 | $90.64 | |
| 86140 | <1% | 18 | $54.69 | |
| 90678 | 0% | 63 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMULL, CINDY (DIRECTOR OF REVENUE MANAGEMENT)
| Provider | Location | Paid |
|---|---|---|
| Geisinger Clinic | Danville, PA | $74.54M |
| Community Medical Center | Scranton, PA | $22.62M |
| Geisinger Clinic | Danville, PA | $14.93M |
| West Shore Advanced Life Support Services, INC. | Danville, PA | $4.41M |
| Geisinger Clinic | Pottsville, PA | $3.39M |
| Geisinger Clinic | Lewistown, PA | $2.93M |
| Geisinger Clinic | Scranton, PA | $2.63M |
| Geisinger Clinic | Wilkes Barre, PA | $2.35M |
| Geisinger Clinic | Danville, PA | $2.28M |
| Geisinger Jersey Shore Hospital | Jersey Shore, PA | $2.17M |
| Geisinger Clinic | Scranton, PA | $1.71M |
| Geisinger Clinic | Tunkhannock, PA | $1.11M |
| Geisinger Clinic | Orwigsburg, PA | $974K |
| Geisinger Clinic | Pittston, PA | $942K |
| Geisinger Clinic | Berwick, PA | $896K |
| Geisinger Clinic Selinsgrove | Selinsgrove, PA | $819K |
| Geisinger Clinic | Philipsburg, PA | $678K |
| Geisinger Clinic | Lewisburg, PA | $557K |
| Geisinger Clinic | Mountain Top, PA | $523K |
| Geisinger Clinic | Kulpmont, PA | $489K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.